Food Science and Technology Department


Department of Food Science and Technology: Faculty Publications

Document Type


Date of this Version



[Letter], Annals of Allergy, Asthma & Immunology 117:6 (2016), pp. 712–714.

doi: 10.1016/j.anai.2016 .09.007


Copyright © 2016 American College of Allergy, Asthma and Immunology. Published by Elsevier. Used by permission.


A previous study found that 137 of 179 cashew nut sensitized children (76.5%) suspected of having cashew nut allergy had a positive double-blind, placebo-controlled food challenge (DBPCFC result), with 63 of 137 children (46%) manifesting subjective and/or objective symptoms to the lowest dose (1 mg of cashew nut protein). The primary aim of this study was to determine the distribution of threshold doses and the eliciting doses (EDs) in this population. The secondary aim was to investigate whether children who reacted to 1 mg of cashew nut (n = 63) could react to even lower doses than 1 mg (low-dose follow-up study).

. . .

In conclusion, the statistically determined ED05 was very low (0.8–1.6 mg of cashew nut protein). Individual patients may react to as little as 0.3 and 0.01 mg of cashew nut protein with mild objective symptoms and subjective symptoms, respectively. However, the low-dose challenge tests were performed only in 12 children, they were not reproducible, and the children reported mainly subjective symptoms, which makes interpreting the low-dose data with caution necessary.